Full Text |
QUERY: Citation Author = "Zepp, C." | MyPDB Login | Search API |
Search Summary | This query matches 9 Structures. |
Structure Determination MethodologyScientific Name of Source OrganismTaxonomyExperimental MethodPolymer Entity TypeRefinement Resolution (Å)Release DateEnzyme Classification NameSymmetry TypeSCOP Classification | 1 to 9 of 9 Structures Page 1 of 1 Sort by
LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE(2002) Protein Sci 11: 418-429
LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE(2002) Protein Sci 11: 418-429
LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE(2002) Protein Sci 11: 418-429
LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE(2002) Protein Sci 11: 418-429
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapyPrabu-Jeyabalan, M., Nalivaika, E.A., King, N.M., Schiffer, C.A. (2003) J Virol 77: 1305-1315
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapyPrabu-Jeyabalan, M., Nalivaika, E.A., King, N.M., Schiffer, C.A. (2003) J Virol 77: 1305-1315
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapyPrabu-Jeyabalan, M., Nalivaika, E.A., King, N.M., Schiffer, C.A. (2003) J Virol 77: 1305-1315
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapyPrabu-Jeyabalan, M., Nalivaika, E.A., King, N.M., Schiffer, C.A. (2003) J Virol 77: 1305-1315
Viability of a Drug-Resistant HIV-1 Protease Variant: Structural Insights for Better Anti-Viral TherapyPrabu-Jeyabalan, M., Nalivaika, E.A., King, N.M., Schiffer, C.A. (2003) J Virol 77: 1306-1315
1 to 9 of 9 Structures Page 1 of 1 Sort by |